Pain Related to Local Anesthetic Administration for Nexplanon Placement

NANot yet recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

February 28, 2026

Conditions
Pain Related to Local Anesthetic Administration for Nexplanon Placement
Interventions
COMBINATION_PRODUCT

we will prepare 3cc of buffered lidocaine consisting of 2.7cc of 1% lidocaine and 0.3cc of 8.4% sodium bicarbonate

Either 3cc of unbuffered lidocaine (control) or 3cc of buffered 1% lidocaine (intervention) will be prepared and administered by the clinician. In a study investigating buffered lidocaine versus unbuffered lidocaine in intrauterine device insertion, investigators prepared 20cc of buffered lidocaine utilizing 18cc of 1% lidocaine (90%) and 2cc of 8.4% sodium bicarbonate (10%). 3 Thus, we will prepare 3cc of buffered lidocaine consisting of 2.7cc of 1% lidocaine and 0.3cc of 8.4% sodium bicarbonate.

OTHER

Unbuffered lidocaine

For the control, 3cc of unbuffered lidocaine will be prepared and administered by the clinician.

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT07008222 - Pain Related to Local Anesthetic Administration for Nexplanon Placement | Biotech Hunter | Biotech Hunter